6.3 Autoimmunity, Hypersensitivity & Serological Markers

Autoimmunity, Hypersensitivity & Serological Markers

A properly functioning, healthy immune system flawlessly distinguishes between "self" and "non-self," actively ignoring host tissues while aggressively attacking and eliminating foreign invaders. A systemic breakdown in this central or peripheral self-tolerance results in autoimmunity, where rogue autoantibodies or autoreactive T cells cause severe, chronic tissue damage. Conversely, an exaggerated, wildly inappropriate response to an otherwise benign environmental antigen is termed hypersensitivity.

Hypersensitivity Reactions (Gell and Coombs Classification)

Hypersensitivity reactions are classically divided into four distinct mechanistic categories. A thorough understanding of these pathways is absolutely crucial for correlating patient clinical symptoms with specific laboratory findings.

Clinical Highlight: Hemolytic Disease of the Fetus and Newborn (HDFN) is a classic Type II hypersensitivity. It occurs most severely when an Rh-negative mother is carrying an Rh-positive fetus. During birth, fetal RBCs enter the maternal circulation, sensitizing the mother to produce anti-D IgG. In subsequent pregnancies, this anti-D IgG crosses the placenta and destroys the fetal RBCs. This is successfully prevented by administering RhoGAM (Rh Immune Globulin) to the mother, which passively clears fetal cells before her immune system can mount a primary response.

Acute Phase Reactants (General Inflammation Markers)

Before launching into highly specific, expensive autoimmune panels, physicians routinely order non-specific markers to assess the general baseline level of systemic inflammation. These are serum proteins whose concentrations change rapidly and dramatically in response to infection, trauma, or active autoimmune flares.

• Erythrocyte Sedimentation Rate (ESR): A classic, albeit older and entirely indirect, measure of inflammation. It measures the physical distance (in millimeters) that red blood cells fall in a vertical, specialized Westergren tube over exactly one hour. Increased levels of acute-phase proteins (especially fibrinogen and various immunoglobulins) neutralize the normal negative zeta potential charge on RBCs, causing them to unnaturally stack together like a roll of coins (rouleaux formation). Rouleaux are significantly heavier and settle faster, leading to a high reported ESR. It is highly useful for tracking chronic inflammatory states over long periods.
• C-Reactive Protein (CRP): A highly sensitive, direct acute-phase protein actively synthesized by the liver in direct response to inflammatory cytokines (like IL-6). CRP levels can spike hundreds of times above normal baseline within a mere 4-6 hours of an acute inflammatory event and drop just as rapidly when the condition is resolved. This makes CRP a vastly superior marker for monitoring rapid acute changes and therapeutic response to acute therapy compared to the slower-moving ESR. A specialized variant, High-sensitivity CRP (hs-CRP), is utilized to precisely assess low-level chronic inflammation related to cardiovascular disease risk.

Autoimmune Serological Markers

The complex laboratory diagnosis of systemic autoimmune rheumatic diseases heavily involves the meticulous detection of specific circulating autoantibodies.

Antinuclear Antibodies (ANA)

Testing for Antinuclear Antibodies is the gold-standard primary screening tool for connective tissue diseases, particularly Systemic Lupus Erythematosus (SLE). ANAs are a diverse group of autoantibodies erroneously directed against various structures deep within the nucleus of mammalian cells (DNA, RNA, histones, centromeres).

Methodology: The definitive screening method is the Indirect Immunofluorescence Assay (IFA) strictly using HEp-2 cells (human epithelioma type 2) fixed on a glass slide. Patient serum is applied. If ANAs are present, they bind to the cell nuclei. Following a meticulous wash step to remove unbound proteins, a fluorescently labeled anti-human IgG is added. The slide is evaluated under a fluorescence microscope in a darkroom.

Interpretation: A positive ANA is highly sensitive for SLE (over 95% of patients are positive), but it is unfortunately not specific (low titers can be routinely found in healthy elderly populations or temporarily associated with severe viral infections). If the IFA screen is positive, the skilled technician notes the specific fluorescence staining pattern, which provides crucial diagnostic clues as to which specific antibodies are present and directly guides downstream confirmatory testing using multiplex bead assays or ELISAs.

Diagnostic Note: The presence of Anti-Sm and Anti-dsDNA is considered highly diagnostic and pathognomonic for SLE. Furthermore, Anti-dsDNA titers correlate directly with ongoing disease activity and strongly predict the risk of severe lupus nephritis.

Markers for Rheumatoid Arthritis (RA)

Rheumatoid Arthritis is a brutal, chronic, systemic inflammatory disorder that primarily targets and affects the synovial joints. The synovial fluid in severe cases will reveal massive infiltration of neutrophils and markedly decreased viscosity. Laboratory diagnosis relies on two major markers.

• Rheumatoid Factor (RF): A classic marker used for decades. RF is paradoxically defined as an autoantibody directed against the Fc portion of the patient's own healthy IgG molecules. Intriguingly, the most common isotype of RF is an IgM antibody (acting as an "IgM anti-IgG"). RF is positive in 70-80% of RA patients. However, it severely lacks specificity and can be frequently positive in Sjögren's syndrome, chronic devastating infections (like chronic Hepatitis C or endocarditis), and a high percentage of healthy older adults.
• Anti-Cyclic Citrullinated Peptide (Anti-CCP): Also formally known as ACPA (Anti-citrullinated protein antibodies). During joint inflammation, normal arginine residues in joint proteins (like filaggrin or vimentin) are biochemically converted to citrulline. RA patients produce aggressive antibodies against these newly citrullinated peptides. Anti-CCP has similar general sensitivity to RF but is exponentially more highly specific for diagnosing true Rheumatoid Arthritis (boasting 90-95% specificity). Strikingly, it often appears in the blood years before overt clinical symptoms manifest, making it an invaluable predictive and early diagnostic tool. A patient positive for both high-titer RF and Anti-CCP has a very high mathematical probability of developing severely aggressive, erosive RA.

Additional Critical Autoimmune Markers

• Celiac Disease: A severe autoimmune enteropathy triggered by gluten. Testing involves screening for IgA Anti-Tissue Transglutaminase (anti-tTG) and IgA Endomysial Antibodies (EMA). Critical laboratory rule: Because IgA deficiency is common in celiac patients, a Total Serum IgA must always be drawn simultaneously to ensure the patient actually produces IgA, avoiding disastrous false-negative results.
• Thyroid Autoimmunity:
  • Hashimoto's Thyroiditis (Hypothyroidism): Diagnosed via the presence of incredibly high titers of Anti-Thyroid Peroxidase (Anti-TPO) and Anti-Thyroglobulin (Anti-Tg), leading to gland destruction.
  • Graves' Disease (Hyperthyroidism): Diagnosed via the presence of Thyrotropin Receptor Antibodies (TRAb) or Thyroid Stimulating Immunoglobulins (TSI), which pathologically mimic TSH and force the gland into extreme overdrive.
• Vasculitis Markers (ANCA): Anti-Neutrophil Cytoplasmic Antibodies are screened via IFA on ethanol-fixed neutrophils. A c-ANCA (cytoplasmic) pattern usually correlates with PR3 antibodies and strongly indicates Granulomatosis with Polyangiitis (formerly Wegener's). A p-ANCA (perinuclear) pattern usually correlates with MPO antibodies, indicating Microscopic Polyangiitis.